Product Portfolio

The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.

RX

- Prescription Medicines

LEVETIRACETAM ARENA 500 mg

New-generation anticonvulsant indicated in the treatment of epilepsy

Film-coated tablets

500 mg

See details

LEVOFLOXACINA ARENA 250 mg

Fluoroquinolone antibiotic, indicated in respiratory and urinary tract infections

Film-coated tablets

250 mg

See details

LEVOFLOXACINA ARENA 500 mg

Fluoroquinolone antibiotic, indicated in respiratory and urinary tract infections

Film-coated tablets

500 mg

See details

LOSARTAN ARENA 100 mg

Angiotensin II receptor antagonist, indicated in the treatment of arterial hypertension

Film-coated tablets

100 mg

See details

LOSARTAN ARENA 25 mg

Angiotensin II receptor antagonist, indicated in the treatment of arterial hypertension

Film-coated tablets

25 mg

See details

LOSARTAN HCT ARENA 100 mg/25 mg

Antihypertensive combination (angiotensin II antagonist + diuretic) for blood pressure control

Film-coated tablets

100 mg/25 mg

See details

LOSARTAN HCT ARENA 50 mg/12.5 mg

Antihypertensive combination (angiotensin II antagonist + diuretic) for blood pressure control

Film-coated tablets

50 mg/12.5 mg

See details

LOVASTATINA ARENA 20 mg

Drug from the statin class, indicated for reducing elevated cholesterol

Tablets

20 mg

See details

LYXIT 12,5 mg

Antidepressant drug with anxiolytic properties, indicated in the treatment of depression

Film-coated tablets

12,5 mg

See details